Clinical Trials Browser

Phase 1/2 × Brain Neoplasms × Doxorubicin × Clear all

NCT05630209 2025-10-02

Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG)

Phase 1/2 Recruiting

Brain Neoplasms

NCT05615623 2025-04-30

Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric DIPG

Phase 1/2 Recruiting

Brain Neoplasms